Vidaglo-D5 Tablet SR

Описание товара

About Vidaglo-D5 Tablet SR

Vidaglo-D5 Tablet SR is a medication containing the active ingredient Dapagliflozin, classified as Diabetes medication. Dapagliflozin, sold under the brand names Farxiga (US) and Forxiga (EU) among others, is a medication used to treat type 2 diabetes. It is also used to treat adults with heart failure and chronic kidney disease.

Key Benefits & Uses

• Used for: 1 INDICATIONS AND USAGE FARXIGA (dapagliflozin) is indicated: • To reduce the risk of sustained eGFR decline, end-stage kidney disease.
• Used for: • To reduce the risk of CV death, hospitalization for he…
• Use only as directed on the product label or by a healthcare professional.

Active Ingredient & Action

Dapagliflozin, the active ingredient in Vidaglo-D5 Tablet SR, belongs to the Diabetes medication class. 1 INDICATIONS AND USAGE FARXIGA (dapagliflozin) is indicated: • To reduce the risk of sustained eGFR decline, end-stage kidney disease, cardiovascular (CV) death, and hospitalization for heart failure in adults with chronic kidney disease at risk of progression. • To reduce the risk of CV death, hospitalization for he…. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Vidaglo-D5 Tablet SR. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Vidaglo-D5 Tablet SR for extended periods without medical advice.